Thus, the conjugate of the present invention has {HEAD ~ one or more improved properties} as compared to commercially available rFVIIa, including increased functional in vivo half life and increased plasma half life, and increased bioavailability and reduced {TAIL ~ sensitivity} to proteolytic degradation 
Thus , the conjugate of the present invention has { HEAD ~ one or more improved properties } as compared to commercially available rFVIIa , including increased functional in vivo half life and increased plasma half life , and increased bioavailability and reduced { TAIL ~ sensitivity } to proteolytic degradation
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH REL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH